Advertisement

Five-Year Extended Hormone Therapy No Better in Breast Cancer

0

Findings compared with two years of extended adjuvant anastrozole in postmenopausal women with hormone-receptor-positive breast cancer

Sickle Cell Disease May Up Risk for Poor COVID-19 Outcomes

0

Sickle cell trait also associated with increased risk for COVID-19-related hospitalization and death, but to a lesser extent

Healthy Lifestyle May Offset Genetic Risk for Cancer

0

For men and women with high genetic risk, five-year cancer incidence down significantly with a favorable lifestyle

DoD Not Protecting Service Members From Toxic ‘Forever Chemicals’: Audit

0

Audit also noted that department is falling short on tracking the health effects from exposure to perfluoroalkyl and polyfluoroalkyl substances

Black Women’s Group Sues Johnson & Johnson Over Baby Powder

0

Lawsuit claims that J&J targeted baby powder ads to Black women despite knowing it contained ingredients that could cause ovarian cancer

Smoking Cessation After NSCLC Diagnosis Cuts Mortality Risk

0

Risks for all-cause mortality, cancer-specific mortality, disease progression reduced for those quitting after diagnosis

Inequalities Found With U.S. Family and Medical Leave Act Requirement

0

Women disproportionately excluded in minimum hours requirement; tenure requirement excludes Blacks, indigenous, multiracial workers

VTE Risk Up for Children With Inflammatory Bowel Disease

0

Venous thromboembolism occurred less often for those with Crohn disease versus ulcerative colitis

Prostate Cancer Surgery Lagged for Black Men During Pandemic

0

Black men less likely than White men to undergo prostatectomy despite similar COVID-19 risk factors, biopsy Gleason grade groups

Racial Disparities Persist in Multiple Myeloma Care, Outcomes

0

Hispanics have higher MM-related in-hospital mortality; recent decline seen in in-hospital mortality for all except NH-Blacks